Education
About Us
Working with TipRanks
Follow Us
Agios Pharmaceuticals (GB:0HB0)
:0HB0
Agios Pharma (0HB0) Ownership Overview
1.50% Insiders
26.09% Mutual Funds
7.38% Other Institutional Investors
18.15% ETFs
46.88% Public Companies and
Individual Investors
The ownership structure of Agios Pharma (GB:0HB0) stock is a mix of institutional, retail, and individual investors. Approximately 51.62% of the company’s stock is owned by Institutional Investors, 1.50% is owned by Insiders, and 46.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 05, 2024 | xxxxxxxxxxxxx | $60459 | |
| Mar 11, 2024 | Kaye Foster Cheek Director | xxxxxxxxxxxxx | $40632 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $256439 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1971600 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $31567320 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $186462952 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,660,866 | Institution | 9.93% | 189,995,646 | |
| 5,431,762 | Institution | 9.52% | 182,306,228 | |
| 4,847,065 | Institution | 8.50% | 162,682,043 | |
| 2,627,667 | Institution | 4.61% | 88,192,388 | |
| 1,379,776 | Institution | 2.42% | 46,309,422 | |
| 1,322,563 | Institution | 2.32% | 44,389,182 | |
| 960,661 | Institution | 1.68% | 32,242,665 | |
| 855,152 | Institution | 1.50% | 28,701,467 | |
| 767,543 | Institution | 1.35% | 25,761,046 | |
| 643,016 | Institution | 1.13% | 21,581,546 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,847,065 | Institution | 8.50% | 162,682,043 | |
| 1,379,776 | Institution | 2.42% | 46,309,422 | |
| 1,322,563 | Institution | 2.32% | 44,389,182 | |
| 767,543 | Institution | 1.35% | 25,761,046 | |
| 643,016 | Institution | 1.13% | 21,581,546 | |
| 612,598 | Institution | 1.07% | 20,560,627 | |
| 569,112 | Institution | 1.00% | 19,101,106 | |
| 493,427 | Institution | 0.87% | 16,560,890 | |
| 482,236 | Institution | 0.85% | 16,185,287 | |
| 373,695 | Institution | 0.66% | 12,542,325 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Agios Pharmaceuticals (GB:0HB0)?
According to the latest TipRanks data, approximately 7.38% of the company's stock is held by institutional investors, 1.50% is held by insiders, and 46.88% is held by retail investors.
What percentage of Agios Pharmaceuticals (GB:0HB0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.38% of Agios Pharmaceuticals (GB:0HB0) stock is held by institutional investors.
What percentage of Agios Pharmaceuticals (GB:0HB0) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.88% of Agios Pharmaceuticals (GB:0HB0) stock is held by retail investors.
Who owns the most shares of Agios Pharmaceuticals (GB:0HB0)?
Andrew J.M. Spokes owns the most shares of Agios Pharmaceuticals (GB:0HB0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.